Prediction of progression of non-muscle invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: A prospective study

被引:0
|
作者
Zwarthoff, Ellen
Burger, Maximilian
Van der Aa, Madelon
Van Oers, Johanna
Brinkmann, Anke
Van der Kwast, Theodorus
Steyerberg, Ewout
Stoehr, Robert
Kirkels, Wim
Denzinger, Stefan
Wild, Peter
Wieland, Wolf
Hofstaedter, Ferdinand
Hartmann, Arndt
机构
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Regensburg, Regensburg, Germany
[3] Toronto Gen Hosp, Toronto, ON, Canada
[4] Univ Hosp Zurich, Zurich, Switzerland
[5] Univ Erlangen Nurnberg, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4951
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
    Burger, Maximilian
    van der Aa, Madelon N. M.
    van Oers, Johanna M. M.
    Brinkmann, Anke
    van der Kwast, Theodorus H.
    Steyerberg, Ewout C.
    Stoehr, Robert
    Kirkels, Wim J.
    Denzinger, Stefan
    Wild, Peter J.
    Wieland, Wolf F.
    Hofstaedter, Ferdinand
    Hartmann, Arndt
    Zwarthoff, Ellen C.
    EUROPEAN UROLOGY, 2008, 54 (04) : 835 - 844
  • [2] Role of the FGFR3 gene mutation status in predicting progression of non- muscle-invasive bladder cancer
    Rolevich, A. I.
    Smal, M. P.
    Krasnyi, S. A.
    Goncharova, R. I.
    ONKOUROLOGIYA, 2015, 11 (03): : 62 - 70
  • [3] Molecular grading with FGFR3 and MIB-1 is highly predictive and reproducible in non-muscle invasive bladder cancer
    van Rhijn, Bas
    Vis, Andre N.
    van der Kwast, Theo H.
    Kirkels, Wim J.
    Radvanyi, Francois
    Chopin, Dominique K.
    Ooms, Bert
    Boeve, Egbert
    Jobsis, Adriaan
    Zwarthoff, Ellen C.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 586 - 586
  • [4] FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
    Neuzillet, Yann
    van Rhijn, Bas W. G.
    Prigoda, Nadia L.
    Bapat, Bharati
    Liu, Liyang
    Bostrom, Peter J.
    Fleshner, Neil E.
    Gallie, Brenda L.
    Zlotta, Alexandre R.
    Jewett, Michael A. S.
    van der Kwast, Theo H.
    VIRCHOWS ARCHIV, 2014, 465 (02) : 207 - 213
  • [5] FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
    Yann Neuzillet
    Bas W. G. van Rhijn
    Nadia L. Prigoda
    Bharati Bapat
    Liyang Liu
    Peter J. Bostrom
    Neil E. Fleshner
    Brenda L. Gallie
    Alexandre R. Zlotta
    Michael A. S. Jewett
    Theo H. van der Kwast
    Virchows Archiv, 2014, 465 : 207 - 213
  • [6] FGFR3 mutations in non-muscle invasive bladder cancer: Prevalence and association with outcome - results of the epicuro study
    Hernandez-Llodra, Silvia
    Lopez-Knowles, Elena
    Lloreta, Josep
    Kogevinas, Manolis
    Amoros, Alex
    Tardon, Adonina
    Serra, Consol
    Garcia-Closas, Reina
    Carrato, Alfredo
    Malats, Nuria
    Real, Francisco X.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] FGFR3 gene mutations screening in non-muscle invasive bladder cancer (NMIBC) in the Tunisian population
    Saidani, Bilel
    Boubaker, Nouha Setti
    Chakroun, Marouen
    Ayed, Haroun
    Ksontini, Meriem
    Naimi, Zeineb
    Meddeb, Khedija
    Saadi, Ahmed
    Rammeh, Soumaya
    Slama, Mohamed Riadh Ben
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [8] THE HYPOXIC REGULATION OF FGFR3 IN NON MUSCLE INVASIVE BLADDER CANCER
    Blick, C.
    McCormick, R.
    Ramachandran, A.
    Cranston, D.
    Catto, J. W. F.
    Harris, A. L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 167 - 167
  • [9] Study of FGFR3 Expression and FGFR3 Mutations in Molecular Subtypes of Muscle Invasive Bladder Cancer
    Kaushal, Seema
    Roy, Charli
    Seth, Amlesh
    Sahoo, Ranjit
    Batra, Atul
    Dinda, Amit
    LABORATORY INVESTIGATION, 2024, 104 (03) : S966 - S967
  • [10] The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
    Sikic, Danijel
    Taubert, Helge
    Breyer, Johannes
    Eckstein, Markus
    Weyerer, Veronika
    Keck, Bastian
    Kubon, Jennifer
    Otto, Wolfgang
    Worst, Thomas S.
    Kriegnnair, Maximilian C.
    Erben, Philipp
    Hartmann, Arndt
    Wullich, Bernd
    Wirtz, Ralph M.
    Wach, Sven
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6567 - 6578